Does nivolumab combined with fluorouracil-based chemotherapy produce higher objective response rate than other immunochemotherapy regimes in metastatic esophageal cancer?: authors reply

Detalles Bibliográficos
Autores principales: Gao, Zhen, Huang, Shujie, Wang, Sichao, Tang, Dezhao, Xu, Wei, Zeng, Ruijie, Qiao, Guibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585616/
https://www.ncbi.nlm.nih.gov/pubmed/37868211
http://dx.doi.org/10.1016/j.lanwpc.2023.100927
_version_ 1785122990342537216
author Gao, Zhen
Huang, Shujie
Wang, Sichao
Tang, Dezhao
Xu, Wei
Zeng, Ruijie
Qiao, Guibin
author_facet Gao, Zhen
Huang, Shujie
Wang, Sichao
Tang, Dezhao
Xu, Wei
Zeng, Ruijie
Qiao, Guibin
author_sort Gao, Zhen
collection PubMed
description
format Online
Article
Text
id pubmed-10585616
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-105856162023-10-20 Does nivolumab combined with fluorouracil-based chemotherapy produce higher objective response rate than other immunochemotherapy regimes in metastatic esophageal cancer?: authors reply Gao, Zhen Huang, Shujie Wang, Sichao Tang, Dezhao Xu, Wei Zeng, Ruijie Qiao, Guibin Lancet Reg Health West Pac Correspondence Elsevier 2023-10-14 /pmc/articles/PMC10585616/ /pubmed/37868211 http://dx.doi.org/10.1016/j.lanwpc.2023.100927 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Correspondence
Gao, Zhen
Huang, Shujie
Wang, Sichao
Tang, Dezhao
Xu, Wei
Zeng, Ruijie
Qiao, Guibin
Does nivolumab combined with fluorouracil-based chemotherapy produce higher objective response rate than other immunochemotherapy regimes in metastatic esophageal cancer?: authors reply
title Does nivolumab combined with fluorouracil-based chemotherapy produce higher objective response rate than other immunochemotherapy regimes in metastatic esophageal cancer?: authors reply
title_full Does nivolumab combined with fluorouracil-based chemotherapy produce higher objective response rate than other immunochemotherapy regimes in metastatic esophageal cancer?: authors reply
title_fullStr Does nivolumab combined with fluorouracil-based chemotherapy produce higher objective response rate than other immunochemotherapy regimes in metastatic esophageal cancer?: authors reply
title_full_unstemmed Does nivolumab combined with fluorouracil-based chemotherapy produce higher objective response rate than other immunochemotherapy regimes in metastatic esophageal cancer?: authors reply
title_short Does nivolumab combined with fluorouracil-based chemotherapy produce higher objective response rate than other immunochemotherapy regimes in metastatic esophageal cancer?: authors reply
title_sort does nivolumab combined with fluorouracil-based chemotherapy produce higher objective response rate than other immunochemotherapy regimes in metastatic esophageal cancer?: authors reply
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585616/
https://www.ncbi.nlm.nih.gov/pubmed/37868211
http://dx.doi.org/10.1016/j.lanwpc.2023.100927
work_keys_str_mv AT gaozhen doesnivolumabcombinedwithfluorouracilbasedchemotherapyproducehigherobjectiveresponseratethanotherimmunochemotherapyregimesinmetastaticesophagealcancerauthorsreply
AT huangshujie doesnivolumabcombinedwithfluorouracilbasedchemotherapyproducehigherobjectiveresponseratethanotherimmunochemotherapyregimesinmetastaticesophagealcancerauthorsreply
AT wangsichao doesnivolumabcombinedwithfluorouracilbasedchemotherapyproducehigherobjectiveresponseratethanotherimmunochemotherapyregimesinmetastaticesophagealcancerauthorsreply
AT tangdezhao doesnivolumabcombinedwithfluorouracilbasedchemotherapyproducehigherobjectiveresponseratethanotherimmunochemotherapyregimesinmetastaticesophagealcancerauthorsreply
AT xuwei doesnivolumabcombinedwithfluorouracilbasedchemotherapyproducehigherobjectiveresponseratethanotherimmunochemotherapyregimesinmetastaticesophagealcancerauthorsreply
AT zengruijie doesnivolumabcombinedwithfluorouracilbasedchemotherapyproducehigherobjectiveresponseratethanotherimmunochemotherapyregimesinmetastaticesophagealcancerauthorsreply
AT qiaoguibin doesnivolumabcombinedwithfluorouracilbasedchemotherapyproducehigherobjectiveresponseratethanotherimmunochemotherapyregimesinmetastaticesophagealcancerauthorsreply

Ejemplares similares